Neoclarityn (Desloratadine)

Desloratadine, the active ingredient in Neoclarityn, is a second‑generation antihistamine presented as an oral tablet for oral use. It treats allergic rhinitis and chronic idiopathic urticaria in adults and children.

GNH USA supplies Neoclarityn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desloratadine is a second‑generation antihistamine that reduces histamine‑mediated symptoms in allergic conditions.

Allergic rhinitis: relieves nasal congestion, sneezing, itching and watery discharge. Chronic idiopathic urticaria: decreases the frequency and severity of hives and associated itching. Seasonal allergic conjunctivitis: alleviates eye itching, redness and tearing.

Desloratadine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate discomfort. - Dry mouth: reduced salivation. - Fatigue: feeling of tiredness. - Nausea: occasional stomach upset. - Somnolence: mild sleepiness in some patients. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or tongue. - Anaphylaxis: severe, life‑threatening allergic reaction. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Tachycardia: rapid heart rate. - Hepatotoxicity: abnormal liver enzyme elevations. - Hematologic abnormalities: rare blood cell count changes.

Before using Neoclarityn, consider the following safety measures.

Hepatic impairment: dose may need adjustment in patients with liver dysfunction. Known hypersensitivity: avoid if the patient has demonstrated allergy to desloratadine or related compounds. Pregnancy: limited data; use only if potential benefit justifies the risk. Breastfeeding: unknown excretion; weigh benefits against possible infant exposure. Concomitant CYP3A4 inhibitors: monitor for increased plasma levels. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Desloratadine can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Ketoconazole: strong CYP3A4 inhibition may raise desloratadine levels. - Erythromycin: can increase plasma concentration, raising side‑effect risk. - Ritonavir: potent CYP3A4 inhibitor, may lead to toxicity.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance sedation. - Other antihistamines: additive sedative effects. - Theophylline: possible increase in theophylline concentrations. - Warfarin: monitor INR as desloratadine may affect anticoagulation. - CNS depressants: watch for enhanced drowsiness.